|

VRB-101 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Oral Ecnoglutide

Pipeline

Phase 2: 1

Top Sponsors

  • Verdiva Bio Dev Limited1

Indications

  • Weight Loss1
  • Overweight1
  • Obesity1

Anniston, Alabama1 trial

A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Clinical Study Site 103

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.